Copyright Reports & Markets. All rights reserved.

Global Diabetic Neurological Disorder Therapeutic Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Diabetic Neurological Disorder Therapeutic Drug
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Diabetic Neurological Disorder Therapeutic Drug by Type
    • 1.3.1 Overview: Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Diabetic Neurological Disorder Therapeutic Drug Consumption Value Market Share by Type in 2023
    • 1.3.3 Capsule
    • 1.3.4 Pills
    • 1.3.5 Other
  • 1.4 Global Diabetic Neurological Disorder Therapeutic Drug Market by Application
    • 1.4.1 Overview: Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Symmetrical Neuropathy
    • 1.4.3 Focal and Multifocal Neuropathy
  • 1.5 Global Diabetic Neurological Disorder Therapeutic Drug Market Size & Forecast
  • 1.6 Global Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast by Region
    • 1.6.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region, (2019-2030)
    • 1.6.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size and Prospect (2019-2030)
    • 1.6.6 South America Diabetic Neurological Disorder Therapeutic Drug Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 AstraZeneca
    • 2.1.1 AstraZeneca Details
    • 2.1.2 AstraZeneca Major Business
    • 2.1.3 AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Product and Solutions
    • 2.1.4 AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 AstraZeneca Recent Developments and Future Plans
  • 2.2 Johnson & Johnson
    • 2.2.1 Johnson & Johnson Details
    • 2.2.2 Johnson & Johnson Major Business
    • 2.2.3 Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Product and Solutions
    • 2.2.4 Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.3 Takeda
    • 2.3.1 Takeda Details
    • 2.3.2 Takeda Major Business
    • 2.3.3 Takeda Diabetic Neurological Disorder Therapeutic Drug Product and Solutions
    • 2.3.4 Takeda Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Takeda Recent Developments and Future Plans
  • 2.4 Mitsubishi Chemical
    • 2.4.1 Mitsubishi Chemical Details
    • 2.4.2 Mitsubishi Chemical Major Business
    • 2.4.3 Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Product and Solutions
    • 2.4.4 Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Mitsubishi Chemical Recent Developments and Future Plans
  • 2.5 Avanir Pharmaceuticals
    • 2.5.1 Avanir Pharmaceuticals Details
    • 2.5.2 Avanir Pharmaceuticals Major Business
    • 2.5.3 Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product and Solutions
    • 2.5.4 Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Avanir Pharmaceuticals Recent Developments and Future Plans
  • 2.6 Dong-A Pharmaceutical Co., Ltd.
    • 2.6.1 Dong-A Pharmaceutical Co., Ltd. Details
    • 2.6.2 Dong-A Pharmaceutical Co., Ltd. Major Business
    • 2.6.3 Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Product and Solutions
    • 2.6.4 Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Dong-A Pharmaceutical Co., Ltd. Recent Developments and Future Plans
  • 2.7 Immune Pharmaceuticals
    • 2.7.1 Immune Pharmaceuticals Details
    • 2.7.2 Immune Pharmaceuticals Major Business
    • 2.7.3 Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product and Solutions
    • 2.7.4 Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Immune Pharmaceuticals Recent Developments and Future Plans
  • 2.8 MediciNova
    • 2.8.1 MediciNova Details
    • 2.8.2 MediciNova Major Business
    • 2.8.3 MediciNova Diabetic Neurological Disorder Therapeutic Drug Product and Solutions
    • 2.8.4 MediciNova Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 MediciNova Recent Developments and Future Plans
  • 2.9 Sangamo BioSciences
    • 2.9.1 Sangamo BioSciences Details
    • 2.9.2 Sangamo BioSciences Major Business
    • 2.9.3 Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Product and Solutions
    • 2.9.4 Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Sangamo BioSciences Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Diabetic Neurological Disorder Therapeutic Drug Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Diabetic Neurological Disorder Therapeutic Drug by Company Revenue
    • 3.2.2 Top 3 Diabetic Neurological Disorder Therapeutic Drug Players Market Share in 2023
    • 3.2.3 Top 6 Diabetic Neurological Disorder Therapeutic Drug Players Market Share in 2023
  • 3.3 Diabetic Neurological Disorder Therapeutic Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Diabetic Neurological Disorder Therapeutic Drug Market: Region Footprint
    • 3.3.2 Diabetic Neurological Disorder Therapeutic Drug Market: Company Product Type Footprint
    • 3.3.3 Diabetic Neurological Disorder Therapeutic Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Diabetic Neurological Disorder Therapeutic Drug Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Diabetic Neurological Disorder Therapeutic Drug Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Diabetic Neurological Disorder Therapeutic Drug Consumption Value by Type (2019-2030)
  • 6.2 North America Diabetic Neurological Disorder Therapeutic Drug Consumption Value by Application (2019-2030)
  • 6.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country
    • 6.3.1 North America Diabetic Neurological Disorder Therapeutic Drug Consumption Value by Country (2019-2030)
    • 6.3.2 United States Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Diabetic Neurological Disorder Therapeutic Drug Consumption Value by Type (2019-2030)
  • 7.2 Europe Diabetic Neurological Disorder Therapeutic Drug Consumption Value by Application (2019-2030)
  • 7.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country
    • 7.3.1 Europe Diabetic Neurological Disorder Therapeutic Drug Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)
    • 7.3.3 France Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region
    • 8.3.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Consumption Value by Region (2019-2030)
    • 8.3.2 China Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)
    • 8.3.5 India Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Diabetic Neurological Disorder Therapeutic Drug Consumption Value by Type (2019-2030)
  • 9.2 South America Diabetic Neurological Disorder Therapeutic Drug Consumption Value by Application (2019-2030)
  • 9.3 South America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country
    • 9.3.1 South America Diabetic Neurological Disorder Therapeutic Drug Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country
    • 10.3.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Diabetic Neurological Disorder Therapeutic Drug Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Diabetic Neurological Disorder Therapeutic Drug Market Drivers
  • 11.2 Diabetic Neurological Disorder Therapeutic Drug Market Restraints
  • 11.3 Diabetic Neurological Disorder Therapeutic Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Diabetic Neurological Disorder Therapeutic Drug Industry Chain
  • 12.2 Diabetic Neurological Disorder Therapeutic Drug Upstream Analysis
  • 12.3 Diabetic Neurological Disorder Therapeutic Drug Midstream Analysis
  • 12.4 Diabetic Neurological Disorder Therapeutic Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Diabetic Neurological Disorder Therapeutic Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    A drug used to treat mental illness caused by diabetes
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Diabetic Neurological Disorder Therapeutic Drug industry chain, the market status of Symmetrical Neuropathy (Capsule, Pills), Focal and Multifocal Neuropathy (Capsule, Pills), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Diabetic Neurological Disorder Therapeutic Drug.
    Regionally, the report analyzes the Diabetic Neurological Disorder Therapeutic Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Diabetic Neurological Disorder Therapeutic Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Diabetic Neurological Disorder Therapeutic Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Diabetic Neurological Disorder Therapeutic Drug industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Capsule, Pills).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Diabetic Neurological Disorder Therapeutic Drug market.
    Regional Analysis: The report involves examining the Diabetic Neurological Disorder Therapeutic Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Diabetic Neurological Disorder Therapeutic Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Diabetic Neurological Disorder Therapeutic Drug:
    Company Analysis: Report covers individual Diabetic Neurological Disorder Therapeutic Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Diabetic Neurological Disorder Therapeutic Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Symmetrical Neuropathy, Focal and Multifocal Neuropathy).
    Technology Analysis: Report covers specific technologies relevant to Diabetic Neurological Disorder Therapeutic Drug. It assesses the current state, advancements, and potential future developments in Diabetic Neurological Disorder Therapeutic Drug areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Diabetic Neurological Disorder Therapeutic Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Diabetic Neurological Disorder Therapeutic Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Capsule
    Pills
    Other
    Market segment by Application
    Symmetrical Neuropathy
    Focal and Multifocal Neuropathy
    Market segment by players, this report covers
    AstraZeneca
    Johnson & Johnson
    Takeda
    Mitsubishi Chemical
    Avanir Pharmaceuticals
    Dong-A Pharmaceutical Co., Ltd.
    Immune Pharmaceuticals
    MediciNova
    Sangamo BioSciences
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Diabetic Neurological Disorder Therapeutic Drug product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Diabetic Neurological Disorder Therapeutic Drug, with revenue, gross margin and global market share of Diabetic Neurological Disorder Therapeutic Drug from 2019 to 2024.
    Chapter 3, the Diabetic Neurological Disorder Therapeutic Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Diabetic Neurological Disorder Therapeutic Drug market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Diabetic Neurological Disorder Therapeutic Drug.
    Chapter 13, to describe Diabetic Neurological Disorder Therapeutic Drug research findings and conclusion.

    Buy now